Beaumont Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.2M Sell
111,216
-3,906
-3% -$910K 1.8% 14
2026
Q1
$28.1M Sell
115,122
-3,093
-3% -$720K 1.93% 12
2025
Q4
$24.5M Sell
118,215
-6,993
-6% -$1.38M 1.61% 19
2025
Q3
$23.2M Sell
125,208
-259
-0.2% -$44.4K 1.55% 19
2025
Q2
$19.2M Sell
125,467
-742
-0.6% -$114K 1.39% 23
2025
Q1
$20.9M Sell
126,209
-33
-0% -$5.16K 1.64% 19
2024
Q4
$18.3M Buy
126,242
+289
+0.2% +$44.8K 1.37% 24
2024
Q3
$20.4M Sell
125,953
-2,260
-2% -$360K 1.6% 22
2024
Q2
$18.7M Sell
128,213
-3,823
-3% -$569K 1.5% 24
2024
Q1
$20.9M Buy
132,036
+555
+0.4% +$88.3K 1.72% 20
2023
Q4
$20.6M Buy
131,481
+585
+0.4% +$89.7K 1.88% 16
2023
Q3
$20.4M Sell
130,896
-4,000
-3% -$660K 2.04% 13
2023
Q2
$22.3M Sell
134,896
-575
-0.4% -$92.8K 2.06% 13
2023
Q1
$21M Sell
135,471
-4,296
-3% -$694K 2.13% 10
2022
Q4
$24.7M Sell
139,767
-6,740
-5% -$1.16M 2.48% 6
2022
Q3
$23.9M Sell
146,507
-1,909
-1% -$323K 2.3% 9
2022
Q2
$26.3M Sell
148,416
-8,735
-6% -$1.56M 2.36% 6
2022
Q1
$27.9M Buy
157,151
+1,410
+0.9% +$240K 2.12% 8
2021
Q4
$26.6M Buy
155,741
+2,429
+2% +$398K 1.93% 11
2021
Q3
$24.8M Sell
153,312
-1,481
-1% -$253K 1.91% 10
2021
Q2
$25.5M Buy
154,793
+2,416
+2% +$400K 1.94% 10
2021
Q1
$25M Buy
152,377
+2,120
+1% +$343K 2.12% 8
2020
Q4
$23.6M Sell
150,257
-15,000
-9% -$2.21M 2.1% 10
2020
Q3
$24.6M Sell
165,257
-1,374
-0.8% -$203K 2.35% 8
2020
Q2
$23.4M Sell
166,631
-4,641
-3% -$676K 2.45% 7
2020
Q1
$22.5M Buy
171,272
+1,392
+0.8% +$197K 2.83% 6
2019
Q4
$24.8M Sell
169,880
-1,794
-1% -$243K 2.44% 4
2019
Q3
$22.2M Buy
171,674
+162
+0.1% +$21.3K 2.22% 5
2019
Q2
$23.9M Buy
171,512
+1,722
+1% +$238K 2.47% 3
2019
Q1
$23.7M Buy
169,790
+4,382
+3% +$587K 2.54% 3
2018
Q4
$21.3M Sell
165,408
-855
-0.5% -$119K 3.48% 4
2018
Q3
$23M Buy
166,263
+5,788
+4% +$769K 2.29% 15
2018
Q2
$19.5M Buy
160,475
+7,099
+5% +$886K 2.06% 11
2018
Q1
$19.7M Buy
153,376
+2,109
+1% +$285K 2.19% 11
2017
Q4
$21.1M Buy
151,267
+608
+0.4% +$84.7K 2.48% 6
2017
Q3
$19.6M Sell
150,659
-2,710
-2% -$359K 2.44% 13
2017
Q2
$20.3M Sell
153,369
-2,437
-2% -$311K 2.63% 4
2017
Q1
$19.4M Buy
155,806
+7,856
+5% +$938K 2.65% 4
2016
Q4
$17M Buy
147,950
+1,344
+0.9% +$155K 2.58% 10
2016
Q3
$17.3M Sell
146,606
-2,518
-2% -$305K 2.74% 5
2016
Q2
$18.1M Buy
149,124
+4,699
+3% +$534K 2.97% 2
2016
Q1
$14.5M Sell
144,425
-4,361
-3% -$451K 2.36% 10
2015
Q4
$15.3M Buy
148,786
+2,590
+2% +$260K 2.52% 10
2015
Q3
$14.2M Hold
146,196
2.06% 11
2015
Q2
$14.2M Sell
146,196
-4,541
-3% -$455K 2.06% 11
2015
Q1
$15.2M Buy
150,737
+226
+0.2% +$23K 0.53% 43
2014
Q4
$15.7M Sell
150,511
-1,323
-0.9% -$139K 0.76% 45
2014
Q3
$16.2M Sell
151,834
-9,956
-6% -$1.03M 1.06% 39
2014
Q2
$16.9M Sell
161,790
-5,485
-3% -$554K 1.2% 37
2014
Q1
$16.4M Sell
167,275
-12,581
-7% -$1.17M 1.35% 29
2013
Q4
$16.5M Buy
179,856
+5,474
+3% +$504K 1.36% 25
2013
Q3
$15.1M Buy
174,382
+2,933
+2% +$263K 1.34% 23
2013
Q2
$14.7M Buy
+171,449
New +$14.5M 1.36% 26

Other funds holding JNJ

Beaumont Financial Advisors's JNJ Position: Q2 2026 in Review

Beaumont Financial Advisors reduced its Johnson & Johnson (JNJ) stake by 3.4% in Q2 2026, selling an estimated $910K and leaving 111,216 shares worth $28.2M. The position accounts for 1.8% of the portfolio, ranked #14.

Beaumont Financial Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Beaumont Financial Advisors held 111,216 shares of Johnson & Johnson worth $28.2M as of Q2 2026.
  • Beaumont Financial Advisors sold 3,906 Johnson & Johnson shares in Q2 2026, an estimated $910K.
  • Johnson & Johnson made up 1.8% of Beaumont Financial Advisors's portfolio in Q2 2026, its #14 holding.
  • Beaumont Financial Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Beaumont Financial Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.